Skip to main content
Explore URMC


Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST

Research Question:
Does the drug bardoxolone help patients with connective tissue disease walk better?

Basic Study Information

This study assesses the safety and efficacy of bardoxolone methyl relative to placebo in patients with connective tissue disease-associated pulmonary arterial hypertension to determine the recommended dose range and evaluate the change from baseline in 6-minute walk distance (6MWD) following 24 weeks of study participation.

Location: University of Rochester - University of Rochester Medical Center

Study Contact Information

Study Coordinator: Research Coordinator
Phone: (585) 486-0869

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search